Researcher
Eric Florence
Affiliations
- HIV/STI Clinic (Research unit)
Member
From1 Oct 2006 → 30 Sep 2022 - HIV/STI Clinic (Research unit)
Member
From30 Sep 2006 → 16 Apr 2015
Projects
1 - 5 of 5
- Ontwikkeling en evaluatie van een gecomputeriseerde interventie voor chemsex ondersteuningFrom19 Nov 2020 → 31 Dec 2021
- Chemified: pilot testing of a mobile application for chemsexcare and supportFrom20 Oct 2020 → 20 Oct 2021
- Hepatitis C virus direct acting antiviral (DAA) treatment success and its impact on transmission dynamics in HIV/HCV co-infected MSMFrom1 Jan 2017 → 31 Dec 2022
- Analytical treatment interruption in HIV positive patients with low viral reservoir to evaluate the potential of a functional cureFrom1 Nov 2014 → 31 Oct 2018
- Operational knowledge to improve HIV early diagnosis and treatment among vulnerable groups in EuropeFrom1 Apr 2014 → 30 Sep 2017
Publications
1 - 10 of 55
- The impact of analytical treatment interruptions and trial interventions on time to viral re-suppression in people living with HIV restarting ART in cure-related clinical studies: a systematic review and meta-analysis(2024)
Authors: MJ Lee, M Eason, A Castagna, G Laura, MA De Scheerder, Abi Janet Riley, P Tebas, Jan Gunst, O Sogaard, Eric Florence, et al.
- Safety and Effectiveness From the Cabotegravir and Rilpivirine Implementation Study in European Locations Study: Phase 3b Hybrid Type III Implementation Study Integrating Cabotegravir plus Rilpivirine Long-Acting Into European Clinical Settings(2024)
Authors: C Jonsson-Oldenbuttel, J. Ghosn, Mark van der Valk, Eric Florence, F. Vera, S. De Wit, A. Rami, F Bonnet, L Hocqueloux, Nikolas Kühn Hove, et al.
Pages: 472-480 - Phylogenetic analysis of Hepatitis C virus infections in a large Belgian cohort using next-generation sequencing of full-length genomes(2023)
Authors: KT Christensen, F Pierard, D Bonsall, R Bowden, E Barnes, Eric Florence, MA Ansari, DM Nguyen, M de Cesare, Frederiek Nevens, et al.
- A truncated HIV Tat demonstrates potent and specific latency reversal activity(2023)
Authors: Ellen Van Gulck, Marion Pardons, Erik Nijs, Nick Verheyen, Koen Dockx, C Van den Eynde, Emilie Battivelli, J Vega, Eric Florence, Brigitte Autran, et al.
- A retrospective, multicentre study on the efficacy, durability, and tolerability of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) for the treatment of HIV in a real-world setting in Belgium(2022)
Authors: R. Nasreddine, Eric Florence, JC Yombi, Sophie Henrard, Gilles Darcis, J. T. Van Praet, L Vandekerckhove, S Allard, R. Demeester, P. Messiaen, et al.
Pages: 116-117 - Safety and effectiveness outcomes from the Carisel study: phase 3b hybrid-3 implementation study integrating cabotegravir plus rilpivirine long-acting into European clinical settings(2022)
Authors: C. Jonsson-Oldenbuettel, J. Ghosn, Marc van der Valk, Eric Florence, F. Vera, M. Ait-Khaled, G. Bontempo, C. Latham, C. A. Gutner, S. Iyer, et al.
Pages: 241-242 - Seroconversion and antibody persistence after yellow fever vaccination in people living with HIV: impact of baseline HIV viral load and yellow fever seropositivity(2022)
Authors: Charlotte Martin, Eric Florence, Cristina Domingo, Marc Delforge, Stéphane De Wit, Nicolas Dauby
Pages: 1-7 - Limited weight impact after switching from boosted protease ihibitors to dolutegravir in persons with human immunodeficiency virus with high cardiovascular risk: a post hoc analysis of the 96-week NEAT-022 randomized trial(2022)
Authors: Laura Waters, Lambert Assoumou, Ana González-Cordón, Stefano Rusconi, Pere Domingo, Mark Gompels, Stephane De Wit, Francois Raffi, Christoph Stephan, Mar Masia, et al.
Pages: 861-870 - Top practices for implementing cabotegravir (CAB) and rilpivirine (RPV) long-acting (LA) in European clinics(2022)
Authors: Julian Olalla, Cassidy Gutner, Miguel Pascual-Bernaldez, Beatriz Hernandez, Samia Dakhia, Laurence Slama, Maria Jose Crusells Canales, Thomas Lutz, Mark van der Valk, Berend van Welzen, et al.
Pages: 27-28 - Self-control as conceptual framework to understand and support people who use drugs during sex(2022)
Authors: Tom Platteau, Eric Florence, John B F de Wit